目录号 | 产品详情 | 靶点 | |
---|---|---|---|
T90597 | |||
SSR504734 是一种具有口服活性、选择性和可逆性的 GlyT1抑制剂 (hGlyT1,rGlyT1,mGlyT1IC50分别为 18、15 和 38 nM)。SSR504734 在精神分裂症、焦虑症和抑郁症模型中表现出活性。 | |||
T13110 | Dopamine Receptor 5-HT Receptor Norepinephrine | ||
Tedatioxetine hydrobromide (Lu AA 24530 hydrobromide) 是一种血清素-去甲肾上腺素-多巴胺再摄取抑制剂 ,也是 5-HT2A、5-HT2C、5-HT3 和 α1A-肾上腺素能受体的拮抗剂,可用于治疗抑郁症和焦虑症。 | |||
TNU0187 | Nucleoside Antimetabolite/Analog | ||
2',5-Difluoro-2'-deoxy-1-arabinosyluracil (2'-Deoxy-2'-fluoro-5-fluoro-arabinouridine) 是一种尿嘧啶核苷类似物,具有潜在的抗癫痫活性和降压活性,可用于研究抗惊厥和焦虑症。 | |||
T1619 | 5-HT Receptor Adrenergic Receptor Histamine Receptor | ||
Trazodone hydrochloride (Trazodone HCl) 是5 羟色胺受体拮抗剂和重吸收抑制剂,用作抗抑郁药,可治疗失眠和焦虑。 | |||
TP1981L | Neuropeptide Y Receptor | ||
Neuropeptide S (Mouse) acetate 是一种生物活性肽。它作为 20 种氨基酸的神经递质/神经调节剂,可用于觉醒、焦虑、运动、摄食行为、记忆和药物成瘾的研究。 | |||
T16489 | GABA Receptor | ||
Darigabat (PF-06372865) 是一种可穿过血脑屏障且具有口服活性和选择性的 GABAA 受体调节剂,具有抗焦虑活性,对 α2、α1 PAM、α2 PAM 的 Ki 值分别为 2.9 nM、21 nM、134 nM。Darigabat 可用于研究焦虑症和癫痫。 | |||
T28294 | GABA Receptor | ||
Panadiplon (FG 10571) 是一种具有选择性的γ-氨基丁酸受体激动剂和5GABAA 的部分激动剂,是一种苯二氮卓类受体,可用于治疗焦虑症。Panadiplon 对 5GABAA 受体与 1GABAA 受体表现出选择性。 | |||
T35707 | NF-κB | ||
3'-Sialyllactose sodium 是一种益生元,具有抗炎活性,可维持免疫稳态。3'-Sialyllactose sodium 可减少压力源引起的焦虑样行为,可用于研究炎症和关节炎。 | |||
T29645 | 5-HT Receptor | ||
Adatanserin hydrochloride (WY50324 hydrochloride) 是一种新型 5-HT(1A)/5-HT(2) 受体配体,具有潜在的神经保护作用,抑制内源性氨基酸缺血性外排,可用于研究抑郁症和焦虑症。 | |||
T4S1999 | Apoptosis HIV Protease | ||
Valepotriate (Valtrate) 是从蜘蛛香分离而来的一种天然产物,是一类新的细胞毒剂和抗肿瘤剂,对 HTC 肝癌细胞是非常有效的细胞毒剂。 它可能对焦虑的精神症状具有潜在的抗焦虑作用。 |
目录号 | 产品名/同用名 | 种属 | 表达系统 | ||
---|---|---|---|---|---|
TMPY-02924 | RGS1 Protein, Human, Recombinant (His) | Human | E. coli | ||
RGS1 (regulator of G-protein signaling 1) has been associated with multiple autoimmune disorders including type I diabetes. RGS1 desensitizes the chemokine receptors CCR7 and CXCR4 that are critical to the localization of T and B cells in lymphoid organs. RGS1 expression may be a prognostic marker for risk stratification and a promising target for the development of a new Multiple myeloma (MM) therapy. The markers in the RGS1 gene might be in linkage disequilibrium with a protective allele that reduces the risk of anxiety and depressive disorders.
|
|||||
TMPY-03991 | DBI Protein, Human, Recombinant (His) | Human | E. coli | ||
The diazepam binding inhibitor (DBI), alternatively known as the acyl-CoA binding protein (ACBP), is involved in multiple biological actions. The polypeptide binds to the peripheral, or mitochondrial, benzodiazepine receptor and facilitates transport of cholesterol to the inner membrane to stimulate steroid synthesis. Through this action, DBI indirectly modulates gamma-aminobutyric acid (GABA)-mediated inhibitory neurotransmission. DBI can be postulated as a candidate gene for psychiatric phenotypes including anxiety, mood, and psychotic disorders. Diazepam Binding Inhibitor (DBI), also called acyl-CoA binding protein (ACBP), is a ubiquitously expressed protein originally identified based on its ability to displace diazepam from its binding site on the GABAA receptor. The mutant allele of the DBI was one of the risk factors for alcohol dependence as for the rs2276596 polymorphism.
|
|||||
TMPY-02648 | PACAP receptor/ADCYAP1R1 Protein, Human, Recombinant (hFc) | Human | HEK293 Cells | ||
Pituitary adenylate cyclase activating polypeptide (PACAP, Adcyap1) activation of PAC1 receptors ( Adcyap1r1) significantly increases excitability of guinea pig cardiac neurons. This modulation of excitability is mediated in part by plasma membrane G protein-dependent activation of adenylyl cyclase and downstream signaling cascades. Studies point to the potential role of the (pituitary) adenylate cyclase activating polypeptide receptor 1 (ADCYAP1R1) gene, which has been implicated in stress response, in posttraumatic stress disorder (PTSD). Pituitary adenylate cyclase-activating polypeptide (PACAP; Adcyap1) and its cognate PAC1 receptor (Adcyap1r1) are expressed in peripheral nociceptive pathways, participate in anxiety-related responses and have been have been linked to posttraumatic stress disorder and other mental health afflictions. Recent studies revealed the role of the PAC1 (ADCYAP1R1) gene variability in vulnerability to posttraumatic stress disorder in women. Due to the relatively high comorbidity of posttraumatic stress disorder and substance use disorder, we hypothesized about possible associations between PAC1 gene and problematic alcohol use.
|
|||||
TMPY-01618 | GLO1 Protein, Mouse, Recombinant (His) | Mouse | E. coli | ||
Lactoylglutathione lyase, also known as Methylglyoxalase, Aldoketomutase, Glyoxalase I, Ketone-aldehyde mutase, S-D-lactoylglutathione methylglyoxal lyase and GLO1, is a member of the glyoxalase I family. GLO1 / Glyoxalase I is a ubiquitous cellular defense enzyme involved in the detoxification of methylglyoxal, a cytotoxic byproduct of glycolysis. Accumulative evidence suggests an important role of GLO1 expression in protection against methylglyoxal-dependent protein adduction and cellular damage associated with diabetes, cancer, and chronological aging. GLO1 / Glyoxalase I has been implicated in anxiety-like behavior in mice and in multiple psychiatric diseases in humans. GLO1 / Glyoxalase I catalyzes the conversion of hemimercaptal, formed from methylglyoxal and glutathione, to S-lactoylglutathione. GLO1 / Glyoxalase I exists in three separable isoforms which originate from two alleles in the genome. These correspond to two homodimers and one heterodimer composed of two subunits showing different electrophoretic properties. GLO1 upregulation may play a functional role in glycolytic adaptations of cancer cells.
|